D. Bowen

415 total citations
12 papers, 286 citations indexed

About

D. Bowen is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, D. Bowen has authored 12 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in D. Bowen's work include Acute Myeloid Leukemia Research (9 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). D. Bowen is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). D. Bowen collaborates with scholars based in United Kingdom, Denmark and Germany. D. Bowen's co-authors include Yayoi Yoshida, Carlo Aul, Sudhir Tauro, L Wang, Martin J. Pippard, MJ Pippard, G. A. Patterson, Ron Kerr, Alan Norris and Jaroslav Čermák and has published in prestigious journals such as British Journal of Haematology, Leukemia and Leukemia Research.

In The Last Decade

D. Bowen

11 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Bowen United Kingdom 7 205 105 99 35 27 12 286
Guillermo Gutiérrez-Espı́ndola Mexico 7 332 1.6× 172 1.6× 82 0.8× 79 2.3× 23 0.9× 11 405
Luxi Song China 11 233 1.1× 88 0.8× 120 1.2× 34 1.0× 68 2.5× 32 347
Wanling Sun China 8 128 0.6× 50 0.5× 80 0.8× 83 2.4× 37 1.4× 41 297
J. Maciejewski United States 7 259 1.3× 107 1.0× 180 1.8× 34 1.0× 30 1.1× 10 345
S. A. Wang United States 6 191 0.9× 68 0.6× 69 0.7× 128 3.7× 14 0.5× 7 267
F Page Australia 4 170 0.8× 47 0.4× 60 0.6× 32 0.9× 27 1.0× 5 225
Carmen Sanzo Spain 5 166 0.8× 84 0.8× 48 0.5× 31 0.9× 24 0.9× 5 211
Yoshitoshi Ohtsuka Japan 9 138 0.7× 62 0.6× 75 0.8× 25 0.7× 38 1.4× 20 208
Thamer Sliwa Austria 8 213 1.0× 144 1.4× 114 1.2× 23 0.7× 86 3.2× 29 329
Sally Jeffries United Kingdom 6 183 0.9× 57 0.5× 66 0.7× 21 0.6× 25 0.9× 10 235

Countries citing papers authored by D. Bowen

Since Specialization
Citations

This map shows the geographic impact of D. Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Bowen more than expected).

Fields of papers citing papers by D. Bowen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Bowen. The network helps show where D. Bowen may publish in the future.

Co-authorship network of co-authors of D. Bowen

This figure shows the co-authorship network connecting the top 25 collaborators of D. Bowen. A scholar is included among the top collaborators of D. Bowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Bowen. D. Bowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Jacobs, Alice K., et al.. (2015). Erythropoietin and the Myelodysplastic Syndrome. Contributions to nephrology. 88. 266–270. 1 indexed citations
2.
Burnett, A.K., Nigel H. Russell, D. Bowen, et al.. (2015). APL of all risk groups is highly curable with a chemo-free combination of attenuated arsenic trioxide and atra. University of Southern Denmark Research Portal (University of Southern Denmark). 100. 1 indexed citations
3.
Swart, Louise de, Alexandra Smith, Pierre Fenaux, et al.. (2011). 7 Management of 1000 patients with low- and intermediate-1 risk myelodysplastic syndromes in the European LeukemiaNet MDS Registry. Leukemia Research. 35. S3–S3. 6 indexed citations
4.
Stauder, Reinhard, A. G. Smith, T. de Witte, et al.. (2011). 34 Health-related quality of life in low-risk MDS patients from the European LeukemiaNet Registry: Correlation with age, gender and decreased survival. Leukemia Research. 35. S12–S12. 1 indexed citations
5.
Bowen, D.. (2009). 19 Chronic myelomonocytic leukemia. Leukemia Research. 33. S15–S15.
6.
Moorman, Anthony V., Eve Roman, Eleanor V. Willett, et al.. (2003). Population-based study of unselected acute myeloid leukemia cases reveals distinct cytogenetic pathways analogous to therapy-related AML/MDS. 1 indexed citations
7.
Tauro, Sudhir, et al.. (2002). Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes. Leukemia. 16(5). 785–790. 35 indexed citations
8.
Tauro, Sudhir, et al.. (2001). Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.. PubMed. 86(10). 1038–45. 39 indexed citations
9.
10.
Wang, L, et al.. (2000). Glutathione S-transferase enzyme expression in hematopoietic cell lines implies a differential protective role for T1 and A1 isoenzymes in erythroid and for M1 in lymphoid lineages.. PubMed. 85(6). 573–9. 48 indexed citations
11.
12.
Aul, Carlo, D. Bowen, & Yayoi Yoshida. (1998). Pathogenesis, etiology and epidemiology of myelodysplastic syndromes.. PubMed. 83(1). 71–86. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillermo Gutiérrez-Espı́ndola Breakdown of academic impact, for papers by Luxi Song Breakdown of academic impact, for papers by Wanling Sun Breakdown of academic impact, for papers by J. Maciejewski Breakdown of academic impact, for papers by S. A. Wang Breakdown of academic impact, for papers by F Page Breakdown of academic impact, for papers by Carmen Sanzo Breakdown of academic impact, for papers by Yoshitoshi Ohtsuka Breakdown of academic impact, for papers by Thamer Sliwa Breakdown of academic impact, for papers by Sally Jeffries
Rankless by CCL
2026